NCT07294703
Factors Associated With Breast Cancer Risks and Outcomes
Recruiting
Not specifiedAges 18+ObservationalMemorial Sloan Kettering Cancer CenterInvestigator-initiated
~750 participants
Updated 2026-04-17 on ClinicalTrials.gov
What's tested:Survey
At a glance
Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recurrence Free Survival/RFS
Measured over 5 years
Conditions
Where it's being run
7 sites across 2 statesNew York4
New Jersey3
Study leadership
- Neha Goel, MD, MPH · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient who is a surgical candidate seen at MSK.
Women 18 years of age and older are eligible to participate in the study.
Exclusion
Patients presenting with a suspicious breast mass or breast cancer less than 1 cm.
Patients presenting to clinic with only microinvasion
Patients who are less than 18 years of age
Patients unable to complete the survey, including IDMC patients.
What this trial measures
- Recurrence Free Survival/RFS5 years
RFS as defined by the STEEP 2.0 guidelines